Asymmetric dimethylarginine: A novel biomarker of gastric mucosal injury?

doi:10.3748/wjg.v17.i17.2178

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3269)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

438

HTML

2603

Figures (1-1)

228

Sum=3269

May 7, 2011 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 7, 2011; 17(17): 2178-2180
Published online May 7, 2011. doi: 10.3748/wjg.v17.i17.2178

Open in New Tab Full Size Figure Download Figure

Figure 1 The hypothesized role of asymmetric dimethylarginine in gastric mucosal injury and the underlying mechanisms. ADMA: Asymmetric dimethylarginine; NO: Nitric oxide.

Citation: Zhang Z, Zou YY, Li FJ, Hu CP. Asymmetric dimethylarginine: A novel biomarker of gastric mucosal injury? World J Gastroenterol 2011; 17(17): 2178-2180
URL: https://www.wjgnet.com/1007-9327/full/v17/i17/2178.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i17.2178